Some patients exhibit blunted hemodynamic response (BHR) to adenosine infusion during stress myocardial perfusion imaging (MPI). Objective: To investigate if patients with BHR are less likely to demonstrate abnormal MPI compared to patients with normal hemodynamic response (NHR). Methods: The frequency of abnormal MPI in 47 consecutive patients with BHR between March 2003 to May 2004 were compared with a 100 consecutive patients with NHR. The definition of BHR is an increase in heart rate < 10 BPM and a decrease of systolic blood pressure < 10 mmHg. Patients with arrhythmias were excluded. All patients underwent Thallium-201 rest SPECT followed by Tc-99m tetrofosmin gated stress SPECT. The characteristics of the abnormal MPI with regards to the presence of ischemia, scar or mixed scar and ischemia as well as scar size were obtained. Additionally, functional information in both groups was recorded. The results were statistically tested for significant differences. Results: The number of males, females and their mean age was 34, 13 and 70 yrs. in the BHR group and 49, 51 and 65 yrs. in the NHR group. There were 15/47 (32%) abnormal MPI in the BHR group versus 22/100(22%) in the NHR group (p=0.2). The 15 abnormal MPI in the BHR group demonstrated ischemia in 2 patients (4.3%), scar in 11(23.4%) and mixed scar and ischemia in 2(4.3%) while the abnormal 22 MPI in the NHR group demonstrated ischemia in 10(10%), scar in 4(4%) and mixed scar and ischemia in 8(8%). The mean left ventricular ejection fraction (LVEF) and end diastolic volume were 55.3+15.9% and 113.1+61.7ml in the BHR group and 60.4+12.0% and 95.6+35.3ml in the NHR group. The statistically significant differences between the two groups were in the number of studies demonstrating scar only (23.4% for BHR versus 4% for NHR, p=0.0007). Patients with BHR also tended to exhibit larger mean scar size (19.9+17.5%) compared to the patients with NHR (11.7+7.4%) (p=0.002). Conclusion: There is no significant difference in the frequency of abnormal MPI in patients with BHR compared to patients with NHR. However, patients with BHR more frequently have scars compared to patients with NHR. Also the scars tend to be significantly larger in patients with BHR.
Keywords: Adenosine, Hemodynamic response, Gated SPECT, Coronary Artery Disease, Accuracy, stress myocardial perfusion imaging
Atheroma Burden and Morphology in Women
Current Pharmaceutical Design Inflammatory Mechanisms in Myocardial Infarction
Current Drug Targets - Inflammation & Allergy Innovative Strategies in In Vivo Apoptosis Imaging
Current Medicinal Chemistry New Insights in Research About Acute Ischemic Myocardial Injury and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Stress Echocardiography
Current Pharmaceutical Design The Role of Endothelial Progenitor Cells and Statins in Endothelial Function: A Review
Cardiovascular & Hematological Agents in Medicinal Chemistry Modulation of Cardiovascular Remodeling with Statins: Fact or Fiction?
Current Vascular Pharmacology The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology NTproBNP: An Important Biomarker in Cardiac Diseases
Current Topics in Medicinal Chemistry Roles of Arterial Baroreceptor Reflex During Bezold-Jarisch Reflex
Current Cardiology Reviews Traditional and Alternative Therapies for Refractory Angina
Current Pharmaceutical Design Effects of Metabolic Approach in Diabetic Patients with Coronary Artery Disease
Current Pharmaceutical Design Perioperative B-blockers in Non-cardiac Surgery: Actual Situation
Current Pharmaceutical Design Regulation of Cardiac Nerves: A New Paradigm in The Management of Sudden Cardiac Death?
Current Medicinal Chemistry Cardiotoxicity of 5-Fluorouracil
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Trends in the Treatment of Cardiovascular Disorders: Site- and Event- Selective Adenosinergic Drugs
Current Medicinal Chemistry Flavonols and Flavones – Protecting Against Myocardial Ischemia/ Reperfusion Injury by Targeting Protein Kinases
Current Medicinal Chemistry Bone Marrow Stem Cell Therapy for Myocardial Angiogenesis
Current Vascular Pharmacology The Coronary Collateral Circulation in Man
Current Cardiology Reviews Targeting Cardiac Mast Cells: Pharmacological Modulation of the Local Renin-Angiotensin System
Current Pharmaceutical Design